Navigation Links
First-Line Use of Abilify Has More Than Doubled Over the Past Year for the Treatment of Newly-Diagnosed Patients in Bipolar Disorder
Date:11/16/2010

BURLINGTON, Mass., Nov. 16, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that first-line use of Bristol Myers-Squibb/Otsuka's Abilify has increased over the past year in newly-diagnosed patients from 4.1 percent patient share to 8.8 percent. According to Treatment Algorithms in Bipolar Disorder, uptake of Abilify in the first-line will continue among surveyed primary care physicians (PCPs): 26 percent of surveyed PCPs who prescribe Abilify indicate they expect to increase their first-line use of this agent over the next two years.

Overall use of Abilify is expected to increase over the next two years as well: 25 percent and 50 percent of surveyed psychiatrists and PCPs, respectively, expect their overall use of Abilify to increase. Surveyed physicians also indicate that use of AstraZeneca's Seroquel XR will grow substantially over the same time period with 28 percent of surveyed psychiatrists and 56 percent of surveyed PCPs expecting that their overall use of Seroquel XR will increase. Additional growth for Seroquel XR will be through greater use in the first line in both psychiatrists and PCPs: 29 percent of surveyed psychiatrists and 36 percent of surveyed PCPs who prescribe Seroquel XR indicate that they expect to increase their use of the agent in the first line over the next two years.

"In light of the anticipated increased use of Seroquel XR, we expect that AstraZeneca's Seroquel will lose some patient share to Seroquel XR, but that loss will not be large enough to unseat Seroquel from its lead position among atypicals. Uptake will be further challenged once generics of Seroquel become available in 2012," said Decision Resources Analysis Alana Simorellis, Ph.D. "Surveyed psychiatrists score Abilify preferentially in terms of ris
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
2. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
3. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
4. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
5. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
6. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
7. Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkins Lymphoma
8. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
9. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
10. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
11. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Pharmaceutical Care Management Association (PCMA) President and ... that could reduce prescription fraud and abuse in Medicare ... Opioid Abuse: Fighting Back on Many Fronts ," sponsored ... The briefing featured several government and industry ... fraud. The Centers for Disease Control and Prevention has ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... GlobalData,s new report, "EU5 Sigmoidoscopes Market Outlook ... EU5 Sigmoidoscopes market. The report provides value, in ... average prices (in US dollars) within market segments ... Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
(Date:9/29/2014)... SAN DIEGO , 29 de septiembre ... aquí en adelante, Daiichi Sankyo) (TSE: 4568) y Ambit ... conjunta hoy que han llegado a un acuerdo de ... todas las acciones ordinarias de Ambit Biosciences a un ... medio de una oferta de licitación seguida de una ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3Daiichi Sankyo adquiere Ambit Biosciences 2Daiichi Sankyo adquiere Ambit Biosciences 3Daiichi Sankyo adquiere Ambit Biosciences 4Daiichi Sankyo adquiere Ambit Biosciences 5Daiichi Sankyo adquiere Ambit Biosciences 6Daiichi Sankyo adquiere Ambit Biosciences 7Daiichi Sankyo adquiere Ambit Biosciences 8
... 11, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... second development candidate, ISIS-AATRx, in its collaboration with GlaxoSmithKline ... payment from GSK for the selection of ISIS-AATRx.  ISIS-AATRx ... caused by alpha-1 antitrypsin deficiency, or AATD, by inhibiting ...
... 11, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
Cached Medicine Technology:Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 2Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 3Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 4North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6North American External Defibrillator Market 7
(Date:9/29/2014)... NAPW honors Hope H. ... Year. She is recognized with this prestigious distinction for ... professional women in the country, the National Association of ... over 600,000 members and nearly 300 Local Chapters. , ... right about turn and applied to a university that ...
(Date:9/29/2014)... 2014 NAPW honors ... Woman of the Year. Dr. Mondloch is recognized with ... medicine As the largest, most-recognized networking organization of professional ... profession, the National Association of Professional Women is a ... nearly 300 Local Chapters. , “Initially my goal was ...
(Date:9/29/2014)... 30, 2014 NAPW honors ... Warm Hearts, Inc., as a 2014 Professional Woman of ... for leadership in home health services. As the largest, ... every industry and profession, the National Association of Professional ... over 600,000 members and nearly 300 Local Chapters. , ...
(Date:9/29/2014)... 29, 2014 Every autumn, as high ... cross country running season takes off! Athletes typically train ... country running season. Zensah®, the leading compression apparel company, ... compression socks for cross country running. ... to reduce delayed onset muscle soreness (DOMS) throughout training ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the ... and was worn by a man, Ötzi the Iceman. ... the direction of using small ornamental purses—which evolved into ... a leading online supplier of fashion accessories, has released ... are fashionable. , For most men, they do ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Hope H. Anderson, President of Hope Nutritional Services, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Victoria J. Mondloch, M.D., Family Medicine and Women's Health, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Rachel L. Gregus, Co-Founder of Safe Hands Warm Hearts, Inc., a 2014 Professional Woman of the Year 2Health News:Muscle Support and Style With New Compression Leg Sleeves For Cross Country Runners 2
... more stress can lead to the growth and spread of ... remarkable finding suggests that stress results in the release of ... released during stress stimulates cancer cells to produce two compounds ... the cells to move easily into the bloodstream and travel ...
... to treat seizures and migraine headaches, can increase the ... Southwestern Medical Center have found. ,A study – ... of topiramate affects kidney-stone formation – appears in the ... ,Several case reports have described an association ...
... from major depression can become symptom-free if they are ... treatments to determine which work best for them, which ... to the mix. ,The largest study on treatments ... that 67 percent of patients achieved a full remission ...
... bird flu virus has been detected in Asia, the British ... for any evidence of bird flu. ,The death ... and parks will be brought to the notice of the ... 1,200 sq Kms area will be brought under surveillance. ...
... world-wide survey which has sought to understand sexual behaviors ... pre-marital sex //in the present day are baseless and ... of this survey are published in The Lancet. ... which showed that many had just a single recent ...
... been grown from umbilical cord blood stem cells for the ... animal experiments for drug testing. ,According to the ... is just the initial phase of generating segments that can ... a mature functioning form. ,Scientists from Newcastle ...
Cached Medicine News:Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 2Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 3Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 3Health News:Artificial Liver from Cord Blood Stem cells 2
Micro-retractor arm 12"....
... designed for the retraction of nerves, vessels, tissue, ... Equalizes brain retraction pressure. Decreases shear injury to ... conjunction with the Budde Halo Retractor. Range of ... 2 mm and 4 mm wide. Quick change ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Medicine Products: